Morgan Stanley’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $5.81M | Buy |
|
|||||
|
2018
Q2 | $4.3M | Buy |
|
|||||
|
2018
Q1 | $1.8M | Buy |
|
|||||
|
2017
Q4 | $714K | Sell |
|
|||||
|
2017
Q3 | $241K | Sell |
|
|||||
|
2017
Q2 | $811K | Buy |
|
|||||
|
2017
Q1 | $251K | Sell |
|
|||||
|
2016
Q4 | $568K | Buy |
|
|||||
|
2016
Q3 | $251K | Buy |
|
|||||
|
2016
Q2 | $244K | Sell |
|
|||||
|
2016
Q1 | $535K | Sell |
|
|||||
|
2015
Q4 | $878K | Sell |
|
|||||
|
2015
Q3 | $1.08M | Buy |
|
|||||
|
2015
Q2 | $671K | Buy |
|
|||||
|
2015
Q1 | $608K | Buy |
|
|||||
|
2014
Q4 | $581K | Sell |
|
|||||
|
2014
Q3 | $651K | Sell |
|
|||||
|
2014
Q2 | $722K | Sell |
|
|||||
|
2014
Q1 | $2.68M | Buy |
|
|||||
|
2013
Q4 | $604K | Sell |
|
|||||
|
2013
Q3 | $1.38M | Sell |
|
|||||
|
2013
Q2 | $1.38M | Buy |
|